Literature DB >> 22396397

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Helen Ling1, Luke A Massey, Andrew J Lees, Peter Brown, Brian L Day.   

Abstract

Repetitive finger tapping is commonly used to assess bradykinesia in Parkinson's disease. The Queen Square Brain Bank diagnostic criterion of Parkinson's disease defines bradykinesia as 'slowness of initiation with progressive reduction in speed and amplitude of repetitive action'. Although progressive supranuclear palsy is considered an atypical parkinsonian syndrome, it is not known whether patients with progressive supranuclear palsy have criteria-defined bradykinesia. This study objectively assessed repetitive finger tap performance and handwriting in patients with Parkinson's disease (n = 15), progressive supranuclear palsy (n = 9) and healthy age- and gender-matched controls (n = 16). The motion of the hand and digits was recorded in 3D during 15-s repetitive index finger-to-thumb tapping trials. The main finding was hypokinesia without decrement in patients with progressive supranuclear palsy, which differed from the finger tap pattern in Parkinson's disease. Average finger separation amplitude in progressive supranuclear palsy was less than half of that in controls and Parkinson's disease (P < 0.001 in both cases). Change in tap amplitude over consecutive taps was computed by linear regression. The average amplitude slope in progressive supranuclear palsy was nearly zero (0.01°/cycle) indicating a lack of decrement, which differed from the negative slope in patients with Parkinson's disease OFF levodopa (-0.20°/cycle, P = 0.002). 'Hypokinesia', defined as <50% of control group's mean amplitude, combined with 'absence of decrement', defined as mean positive amplitude slope, were identified in 87% of finger tap trials in the progressive supranuclear palsy group and only 12% in the Parkinson's disease OFF levodopa group. In progressive supranuclear palsy, the mean amplitude was not correlated with disease duration or other clinimetric scores. In Parkinson's disease, finger tap pattern was compatible with criteria-defined bradykinesia, characterized by slowness with progressive reduction in amplitude and speed and increased variability in speed throughout the tap trial. In Parkinson's disease, smaller amplitude, slower speed and greater speed variability were all associated with a more severe Unified Parkinson's Disease Rating Scale motor score. Analyses of handwriting showed that micrographia, defined as smaller than 50% of the control group's mean script size, was present in 75% of patients with progressive supranuclear palsy and 15% of patients with Parkinson's disease (P = 0.022). Most scripts performed by patients with progressive supranuclear palsy did not exhibit decrements in script size. In conclusion, patients with progressive supranuclear palsy have a specific finger tap pattern of 'hypokinesia without decrement' and they do not have criteria-defined limb bradykinesia. Similarly, 'micrographia' and 'lack of decrement in script size' are also more common in progressive supranuclear palsy than in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396397      PMCID: PMC3326257          DOI: 10.1093/brain/aws038

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  51 in total

Review 1.  Parkinson revisited: pathophysiology of motor signs.

Authors:  Mark Hallett
Journal:  Adv Neurol       Date:  2003

Review 2.  Functional neuroanatomy of the basal ganglia in Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Adv Neurol       Date:  2003

3.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Authors:  Andrew J Hughes; Susan E Daniel; Yoav Ben-Shlomo; Andrew J Lees
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

4.  Micrographia in Parkinson's disease.

Authors:  J E McLennan; K Nakano; H R Tyler; R S Schwab
Journal:  J Neurol Sci       Date:  1972-02       Impact factor: 3.181

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.

Authors:  Y Tsuboi; J Slowinski; K A Josephs; W G Honer; Z K Wszolek; D W Dickson
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

7.  Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.

Authors:  H R Morris; G Gibb; R Katzenschlager; N W Wood; D P Hanger; C Strand; T Lashley; S E Daniel; A J Lees; B H Anderton; T Revesz
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

8.  Impairment of individual finger movements in Parkinson's disease.

Authors:  Rocco Agostino; Antonio Currà; Morena Giovannelli; Nicola Modugno; Mario Manfredi; Alfredo Berardelli
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

9.  Micrographia secondary to lenticular lesions.

Authors:  Pascal Derkinderen; Sophie Dupont; Jean-Sébastien Vidal; François Chedru; Marie Vidailhet
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

10.  Substantia nigra pars reticulata neurons in Parkinson's disease.

Authors:  C D Hardman; D A McRitchie; G M Halliday; H R Cartwright; J G Morris
Journal:  Neurodegeneration       Date:  1996-03
View more
  41 in total

1.  Neural correlates underlying micrographia in Parkinson's disease.

Authors:  Tao Wu; Jiarong Zhang; Mark Hallett; Tao Feng; Yanan Hou; Piu Chan
Journal:  Brain       Date:  2015-11-02       Impact factor: 13.501

2.  Balancing out dwelling and moving: optimal sensorimotor synchronization.

Authors:  Ignasi Cos; Benoît Girard; Emmanuel Guigon
Journal:  J Neurophysiol       Date:  2015-04-15       Impact factor: 2.714

Review 3.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

Review 4.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

5.  Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.

Authors:  Sara Varanese; Paolo Di Ruscio; Leila Ben M' Barek; Astrid Thomas; Marco Onofrj
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

6.  Impact of regional striatal dopaminergic function on kinematic parameters of Parkinson's disease.

Authors:  Myung Jun Lee; Sha-Lom Kim; Chul Hyoung Lyoo; J O Rinne; Myung-Sik Lee
Journal:  J Neural Transm (Vienna)       Date:  2014-08-22       Impact factor: 3.575

Review 7.  Motor automaticity in Parkinson's disease.

Authors:  Tao Wu; Mark Hallett; Piu Chan
Journal:  Neurobiol Dis       Date:  2015-06-21       Impact factor: 5.996

Review 8.  The Phenomenology of Parkinson's Disease.

Authors:  Christopher W Hess; Mark Hallett
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 9.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

10.  Quantifying Parkinson's disease finger-tapping severity by extracting and synthesizing finger motion properties.

Authors:  Yuko Sano; Akihiko Kandori; Keisuke Shima; Yuki Yamaguchi; Toshio Tsuji; Masafumi Noda; Fumiko Higashikawa; Masaru Yokoe; Saburo Sakoda
Journal:  Med Biol Eng Comput       Date:  2016-03-31       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.